Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Open Forum Infectious Diseases|January 30, 2020
Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel Staphylococcus aureus 4-Antigen Vaccine (SA4Ag)C Buddy Creech, Robert W Frenck, Anne Fiquet, et al.The Journal of Infectious Diseases|November 9, 2022
Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in AdultsJoseph Eiden, Carlos Fierro, Howard Schwartz, et al.Vaccine|February 25, 2015
A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adultsMichael Nissen, Helen Marshall, Peter Richmond, et al.The Lancet. Infectious Diseases|July 14, 2024
Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65-85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trialJoseph Eiden, Carlos Fierro, Alexander White, et al.The Lancet. Infectious Diseases|October 18, 2016
Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trialHelen S Marshall, Peter C Richmond, Johannes Beeslaar, et al.The Lancet. Infectious Diseases|May 10, 2012
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trialPeter C Richmond, Helen S Marshall, Michael D Nissen, et al.Journal of the Pediatric Infectious Diseases Society|September 26, 2015
Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy AdolescentsTimo Vesikari, Lars Østergaard, Javier Diez-Domingo, et al.Journal of Clinical Microbiology|August 28, 2015
Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate CollectionsC Hal Jones, Naglaa Mohamed, Eduardo Rojas, et al.Vaccine|December 6, 2016
Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 studyRobert W Frenck, C Buddy Creech, Eric A Sheldon, et al.Vaccine|November 22, 2016
Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trialC Buddy Creech, Robert W Frenck, Eric A Sheldon, et al.Pageof 4